|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.60 INR | -2.00% |
|
-6.26% | +63.58% |
| 05-21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 05-20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.3B 65.67M 57.73M 53.74M 49.35M 92.67M 93.89M 639M 249M 3.11B 247M 241M 10.75B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.16B 74.67M 65.64M 61.1M 56.11M 105M 107M 726M 284M 3.54B 280M 274M 12.22B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -2.00% | ||
| 1 week | -6.26% | ||
| Current month | -5.39% | ||
| 1 month | -5.05% | ||
| 3 months | +40.77% | ||
| 6 months | +65.10% | ||
| Current year | +63.58% |
| 1 week | 117.6 | 122.5 | |
| 1 month | 111.5 | 126.3 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -6.26% | +3.38% | +3.75% | 66.73M | ||
| +1.68% | +2.13% | +16.17% | +77.49% | 48.36B | ||
| +1.52% | +2.95% | +60.39% | +112.28% | 35.8B | ||
| -0.09% | -0.66% | -8.03% | +31.90% | 11.83B | ||
| -0.05% | -3.10% | +13.50% | +77.95% | 11.48B | ||
| +0.56% | -0.37% | +37.53% | +142.08% | 9.01B | ||
| +0.18% | +0.58% | +49.62% | -9.13% | 6.99B | ||
| +0.95% | -2.00% | +12.78% | +32.58% | 6.7B | ||
| +0.18% | -1.77% | +2.36% | +172.36% | 6.42B | ||
| +3.51% | -10.57% | -31.55% | +0.09% | 5.3B | ||
| Average | +0.64% | -1.52% | +15.61% | +64.14% | 14.2B | |
| Weighted average by Cap. | +1.17% | -0.15% | +25.52% | +81.59% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.53M 34.75M 32.35M 29.71M 55.79M 56.53M 385M 150M 1.87B 148M 145M 6.47B | 3.74B 39.04M 34.32M 31.95M 29.34M 55.09M 55.82M 380M 148M 1.85B 147M 143M 6.39B |
| Net income | 122M 1.27M 1.12M 1.04M 953K 1.79M 1.81M 12.34M 4.82M 60.07M 4.76M 4.66M 208M | 58.38M 609K 535K 498K 458K 859K 870K 5.92M 2.31M 28.83M 2.29M 2.24M 99.64M |
| Net Debt | 1.16B 12.07M 10.61M 9.88M 9.07M 17.04M 17.26M 117M 45.86M 572M 45.31M 44.34M 1.98B | 863M 9M 7.91M 7.36M 6.76M 12.7M 12.87M 87.54M 34.19M 426M 33.78M 33.06M 1.47B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | ₹117.60 | -2.00% | 995 |
| 26-07-24 | ₹120.00 | -0.04% | 2,214 |
| 26-07-23 | ₹120.05 | -2.00% | 500 |
| 26-07-21 | ₹122.50 | -2.00% | 400 |
| 26-07-20 | ₹125.00 | -0.36% | 2,296 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















